Jade Biosciences, Inc.
JBIO
$24.71
$0.903.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -153.24M | -129.61M | -127.41M | -- | -- |
| Total Depreciation and Amortization | 39.00K | 35.00K | 26.00K | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.13M | 30.00M | 40.89M | -- | -- |
| Change in Net Operating Assets | -3.44M | -438.00K | -8.20M | -- | -- |
| Cash from Operations | -123.51M | -100.01M | -94.69M | -- | -- |
| Capital Expenditure | -60.00K | -196.00K | -196.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -352.91M | -255.28M | -246.81M | -- | -- |
| Cash from Investing | -352.97M | -255.48M | -247.01M | -- | -- |
| Total Debt Issued | -205.00M | 0.00 | 0.00 | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 578.95M | 385.43M | 385.38M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -11.06M | -24.76M | -24.62M | -- | -- |
| Cash from Financing | 362.89M | 360.67M | 360.77M | -- | -- |
| Foreign Exchange rate Adjustments | -98.00K | -28.00K | -21.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -113.69M | 5.16M | 19.05M | -- | -- |